会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • APPARATUS FOR THE EXTRACORPOREAL TREATMENT OF BLOOD
    • 用于血液提取物治疗的装置
    • US20160354534A1
    • 2016-12-08
    • US15242775
    • 2016-08-22
    • University of Limerick
    • Jakki CooneyTodd Fumio KagawaEdmond Magner
    • A61M1/36C12N9/52A61M1/34C12N11/14
    • A61M1/3687A61L33/0047A61M1/3496A61M1/3689C12N9/52C12N11/14C12Y304/2111
    • An apparatus for the extracorporeal treatment of blood comprising an extracorporeal blood circuit (2), a pump (6) configured to provide fluid displacement within the extracorporeal blood circuit, and a reaction chamber (8) connected to the extracorporeal blood circuit and configured to receive blood or plasma from the circuit and treat the blood or plasma. The reaction chamber comprises a protease enzyme immobilized to a support, in which the protease enzyme is specific for, and capable of irreversibly cleaving, a human C5a present in the blood or plasma, wherein the abundance of the human C5a in the treated blood or plasma is less than that in the untreated blood or plasma. The apparatus finds utility in the extracorporeal treatment of blood from patients with inflammatory conditions, especially auto-immune disease and sepsis.
    • 一种用于血液体外处理的装置,包括体外血液回路(2),构造成在体外血液回路内提供流体置换的泵(6)以及连接到体外血液回路并被配置为接收 来自电路的血液或血浆,治疗血液或血浆。 反应室包含固定在载体上的蛋白酶,其中蛋白酶对血液或血浆中存在的人C5a具有特异性,并能够不可逆地切割,其中处理的血液或血浆中的人C5a的丰度 比未经处理的血液或血浆中的少。 该装置可用于体外治疗患有炎症状况的患者的血液,特别是自身免疫疾病和败血症。
    • 5. 发明申请
    • APPARATUS FOR THE EXTRACORPOREAL TREATMENT OF BLOOD
    • 用于血液提取物治疗的装置
    • US20150166978A1
    • 2015-06-18
    • US14314387
    • 2014-06-25
    • University of Limerick
    • Jakki CooneyTodd Fumio KagawaEdmond Magner
    • C12N11/14A61L33/00C12N9/52
    • A61M1/3687A61L33/0047A61M1/3496A61M1/3689C12N9/52C12N11/14C12Y304/2111
    • An apparatus for the extracorporeal treatment of blood comprising an extracorporeal blood circuit (2), a pump (6) configured to provide fluid displacement within the extracorporeal blood circuit, and a reaction chamber (8) connected to the extracorporeal blood circuit and configured to receive blood or plasma from the circuit and treat the blood or plasma. The reaction chamber comprises an protease enzyme immobilized to a support, in which the protease enzyme is specific for, and capable of irreversibly cleaving, a human C5a present in the blood or plasma, wherein the abundance of the human C5a in the treated blood or plasma is less than that in the untreated blood or plasma. The apparatus finds utility in the extracorporeal treatment of blood from patients with inflammatory conditions, especially auto-immune disease and sepsis.
    • 一种用于血液体外处理的装置,包括体外血液回路(2),构造成在体外血液回路内提供流体置换的泵(6)以及连接到体外血液回路并被配置为接收 来自电路的血液或血浆,治疗血液或血浆。 反应室包含固定在载体上的蛋白酶,其中蛋白酶对血液或血浆中存在的人C5a具有特异性,并能够不可逆地裂解,其中处理的血液或血浆中的人C5a的丰度 比未经处理的血液或血浆中的少。 该装置可用于体外治疗患有炎症状况的患者的血液,特别是自身免疫疾病和败血症。
    • 9. 发明授权
    • Process for preparing biologically compatible polymers and their use in
medical devices
    • 制备生物相容性聚合物的方法及其在医疗器械中的应用
    • US5945457A
    • 1999-08-31
    • US942571
    • 1997-10-01
    • Nicolai A. PlateLev I. ValuevLubov D. UzhinovaVladimir A. Sinani
    • Nicolai A. PlateLev I. ValuevLubov D. UzhinovaVladimir A. Sinani
    • A61L33/00A61L33/06A01N1/00A01N1/02
    • A61L33/0047A61L33/0005A61L33/0041A61L33/06Y10S524/916
    • A hemocompatible composition comprising a polymer containing at least one pharmacologic material chemically bonded to a polymer backbone. Such compositions may be obtained by reacting a pharmacologic material with a compound containing a polymerizable group (e.g., an acyl halide) and thereafter either copolymerizing the acylated material with one or more copolymerizable monomers or first irradiating a backbone polymer and thereafter grafting the acylated pharmacologic material onto the irradiated polymer. The resulting products are hemocompatible and may be used in the manufacture of medical devices which come in contact with blood or other bodily fluids. The advantage of chemically bonded pharmacologic materials is that they are not leached out and retain their pharmaceutical effectiveness for a long period of time. The compositions may contain one or more additional pharmacologic materials which are physically admixed with polymers containing bonded pharmacologic materials.
    • 一种血液相容性组合物,其包含含有至少一种与聚合物主链化学键合的药理学材料的聚合物。 这样的组合物可以通过使药物材料与含有可聚合基团的化合物(例如酰基卤)反应,然后将酰化物质与一种或多种可共聚单体共聚,或者首先辐照骨架聚合物,然后将酰化药理学材料 到被照射的聚合物上。 所得产品是血液相容性的并且可用于制造与血液或其它体液接触的医疗装置。 化学结合的药理学材料的优点是它们不会被浸出并长期保持其药物有效性。 组合物可以含有一种或多种另外的药物物质,其与含有结合的药理学材料的聚合物物理混合。
    • 10. 发明授权
    • Periodate oxidative method for attachment of biomolecules to medical
device surfaces
    • 用于将生物分子附着到医疗器械表面的高碘酸氧化法
    • US5945319A
    • 1999-08-31
    • US1994
    • 1997-12-31
    • James R. Keogh
    • James R. Keogh
    • A61L27/24A61L27/28A61L27/34A61L29/08A61L31/08A61L31/10A61L33/00A61L33/12A61L33/18C12N11/00G01N33/543C07K1/00A61K38/43
    • A61L33/128A61L27/24A61L27/28A61L27/34A61L29/085A61L31/08A61L31/10A61L33/0011A61L33/0029A61L33/0047A61L33/0082A61L33/12A61L33/18Y10S530/81Y10S530/811Y10S530/815Y10S530/816
    • Methods are provided for forming a coating of an immobilized biomolecule on a surface of a medical device to impart improved biocompatibility for contacting tissue and bodily fluids. A 2-aminoalcohol moiety of a biomolecule is oxidized with a periodate to an aldehyde moiety which is reacted with an amine moiety on the surface of a medical device to form an imine moiety, and the imine moiety is reduced to form an amine linkage immobilizing a coating of the biomolecule on the surface. In another method, a biomolecule coating containing an amine moiety and a 2-aminoalcohol moiety is immobilized on the surface of a medical device, the 2-aminoalcohol moiety is oxidized with a periodate to an aldehyde moiety which is reacted with the amine moiety to form an imine moiety, and the imine moiety is reduced to form a secondary amine and crosslink the coating. Each biomolecule may contain an amine moiety and a 2-aminoalcohol moiety, and the aldehyde moiety of one biomolecule resulting from periodate oxidation may react with the amine moiety of another biomolecule. In a further embodiment, a 2-aminoalcohol moiety on the surface of a medical device is oxidized with a periodate to an aldehyde moiety, and an amine moiety of a biomolecule is reacted with the aldehyde moiety to form an imine moiety which is reduced to form an amine linkage immobilizing the biomolecule on the surface.
    • 提供了用于在医疗装置的表面上形成固定的生物分子的涂层的方法,以提高用于接触组织和体液的生物相容性。 生物分子的2-氨基醇部分用高碘酸酯氧化成醛部分,其与医疗器械表面上的胺部分反应以形成亚胺部分,并且亚胺部分被还原以形成胺连接, 在表面上涂覆生物分子。 在另一种方法中,将包含胺部分和2-氨基醇部分的生物分子包被固定在医疗装置的表面上,2-氨基醇部分被高碘酸酯氧化成醛部分,其与胺部分反应形成 亚胺部分,并且亚胺部分被还原以形成仲胺并交联涂层。 每个生物分子可以含有胺部分和2-氨基醇部分,并且由高碘酸氧化产生的一个生物分子的醛部分可能与另一种生物分子的胺部分反应。 在另一个实施方案中,医疗器械表面上的2-氨基醇部分被高碘酸酯氧化成醛部分,并且生物分子的胺部分与醛部分反应以形成亚胺部分,其被还原形成 将生物分子固定在表面上的胺键。